Earnings Feed
Start Free
Acurx Pharmaceuticals, Inc.·4

Jan 4, 4:24 PM ET

LUCI DAVID P 4

4 · Acurx Pharmaceuticals, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-03
Acurx Pharmaceuticals, Inc.ACXP
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
  • Exercise/Conversion

    Warrants for Common Stock

    2024-01-03−19,737→ 0 total
    Exercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-03$3.55/sh+19,737$70,066→ 1,048,197 total
Holdings

  • Common Stock

    (indirect: By Spouse)
    15,083

  • Common Stock

    (indirect: By Children)
    35,000

Documents

1 file
  • 4
    tm242052-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT